Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Sargramostim by Partner Therapeutics for Hematopoietic Stem Cell Transplantation: Likelihood of Approval
Sargramostim is under clinical development by Partner Therapeutics and currently in Phase II for Hematopoietic Stem Cell Transplantation. According to...
Data Insights
Sargramostim by Partner Therapeutics for Acute Respiratory Failure: Likelihood of Approval
Sargramostim is under clinical development by Partner Therapeutics and currently in Phase II for Acute Respiratory Failure. According to GlobalData,...